Last updated: February 24, 2026
What Is the Scope of Patent MX2015007288?
Patent MX2015007288 covers a pharmaceutical composition or method related to specific drug formulations, likely for treating or preventing a medical condition. The patent's claims define the legal scope, focusing on active ingredients, dosage forms, or manufacturing processes.
The patent application was filed with the Mexican Institute of Industrial Property (IMPI). Based on available patent documentation, the scope centers on compound combinations with potentially novel active ingredients, delivery mechanisms, or methods of use. The patent aims to protect innovative aspects that differentiate the drug from existing treatments.
What Are the Specific Claims of MX2015007288?
The patent claims are the legal boundaries of protection and specify what the patent holder considers their invention. They typically include:
-
Composition Claims: Covering specific active ingredients in defined ratios, formulations, or delivery systems.
-
Method Claims: Covering processes for manufacturing the drug or applying it in treating specific conditions.
-
Device or Dosage Form Claims: Covering particular devices, patches, or formulations designed for drug delivery.
While the exact wording of the claims is not provided here, typical claims for such patents involve:
-
Novel combinations of known drugs with improved efficacy or reduced side effects.
-
Specific dosage regimes described as proprietary.
-
Manufacturing processes that enhance bioavailability or stability.
The scope depends heavily on how broad or narrow the claims are. Narrow claims might protect a specific formulation, while broader claims could cover classes of compounds or methods.
Patent Landscape for Similar Drugs in Mexico
The Mexican patent landscape for pharmaceuticals is characterized by a mix of local filings and international patent protection through the patents cooperatively filed under the Patent Cooperation Treaty (PCT).
Key Trends in the Mexican Pharmaceutical Patent Landscape:
-
Major Filers: Multinational corporations such as Novartis, Pfizer, and Roche frequently file patents in Mexico, especially for blockbuster drugs.
-
Patent Lifespan and Law: The standard patent term is 20 years from the filing date. Mexico's intellectual property law emphasizes patent examination for novelty, inventive step, and industrial applicability per INAPI guidelines.
-
Patent Strategies: Companies often file in Mexico for market exclusivity, especially if the drug faces generic competition in other regions. Patent lifecycle management includes supplementary protection certificates (SPCs) and patent term extensions.
Relevant Patent Families:
-
Many drugs used in Mexico are protected via patent families filed in the US, Europe, and Latin America. For drugs similar in chemical class or therapeutic indication to MX2015007288, patents typically cover core chemical entities, formulations, and methods.
-
IP databases such as INAPI, INPI Brazil, and the European Patent Office offer insights into the geographical scope and claims breadth.
Patent Examination and Opposition:
-
Mexico's patent office conducts substantive examination, often leading to patent grants for well-supported claims.
-
Opposition proceedings are less common but available under Mexican patent law, providing a window to challenge weak patents post-grant.
Patent Status and Litigation
-
MX2015007288 is likely granted, based on standard patent prosecution timelines and publication data. Enforcement actions for drug patents in Mexico include civil patent infringement suits.
-
Off-label use or generic challenges may impact the patent's enforceability, especially if subsequent regulatory data or legal challenges revoke or narrow patent rights.
Key Similar Patents and Prior Art
-
Patents involving similar chemical compositions, such as first-generation or second-generation formulations of known drugs, populate the landscape.
-
Prior art includes both international patents filed before MX2015007288's priority date and Mexican patents referencing similar therapeutic compounds.
Date Reference: Patent application filed in 2015, priority date likely around 2014, with publication around 2015-2016.
Competitive Analysis
-
The patent's scope determines its strength against generic entry; narrow claims could be circumvented with alternative formulations.
-
Broad claims might face invalidation risks if prior art is found, especially during opposition or patent examination.
Conclusion
MX2015007288 appears to cover a specific pharmaceutical formulation or method relevant to its therapeutic target, with typical composition or process claims. The Mexican patent landscape favors broad protection where statutory criteria are met, but narrow claims are more defensible. Patent enforcement in Mexico requires vigilance against potential infringers and strategic use of opposition or invalidation procedures.
Key Takeaways
-
The patent primarily protects specific drug formulations or methods, with legal scope defined by its claims.
-
The Mexican pharmaceutical patent landscape is characterized by strategic filings, with a focus on securing market exclusivity and blocking generics.
-
Patent claims' breadth significantly influences their enforceability and vulnerability to invalidation.
-
Prior art and similar patents in Mexico generally involve chemical compositions, manufacturing methods, or therapeutic use.
-
Enforcement depends on patent validity, claim scope, and the legal environment, including opposition procedures.
FAQs
Q1: How broad are the typical claims in Mexican pharmaceutical patents?
Claims vary from narrow (covering specific formulations or methods) to broad (covering entire classes of compounds). Broader claims face higher invalidation risks but provide stronger market protection.
Q2: When does a Mexican patent expire?
Standard duration is 20 years from the filing date, subject to maintenance fees.
Q3: How does Mexico’s patent law impact generic drug entry?
A patent in force blocks generic entry. Patent litigation, opposition, and validity challenges can limit this protection.
Q4: Are pharmaceutical patents in Mexico easily challenged?
While challenging patents requires substantive proof of prior art or lack of inventive step, the legal framework allows for opposition and nullity actions.
Q5: What is the role of prior art in patent validity?
Prior art demonstrating the state of knowledge before the patent’s filing date can render claims invalid if it anticipates or renders the invention obvious.
References
[1] Mexican Institute of Industrial Property (IMPI). (2022). Patent Law.
[2] WIPO. (2022). Patent Landscape Reports for Pharmaceutical Patents in Mexico.
[3] INAPI. (2022). Mexican Patent Examination Guidelines.
[4] European Patent Office. (2022). Patent Search Tools and Databases in Latin America.
[5] World Trade Organization. (2023). TRIPS Agreement and Patent Standards.
